News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BG Medicine (BGMD) Announces Schedule of Events Related to Galectin-3 at the 17th Annual Scientific Meeting of the Heart Failure Society of America


9/19/2013 9:48:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., Sept. 19, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders announced today a series of events related to galectin-3 and heart failure during the 17th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) taking place on September 22nd-25th, 2013 in Orlando, Florida.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES